CGx Testing and Kickbacks Remain Key Enforcement Targets
In our latest roundup, schemes involving cancer genetic testing and kickbacks remain the most common, but there were some surprises.
In our latest roundup, schemes involving cancer genetic testing and kickbacks remain the most common, but there were some surprises.
The agency’s latest report to Congress shows that while enforcement activity is returning to pre-pandemic levels, recoveries are still down.
Co-owners sentenced to three years each for paying millions in kickbacks for referrals to their Brooklyn-based facilities.
While civil actions, criminal actions, and exclusions are up, the increased activity isn’t yet reflected in total recoveries.
Enforcement actions over our most recent coverage period were related to other areas of the healthcare industry.